-
Je něco špatně v tomto záznamu ?
Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review)
O. Kodet, J. Kučera, K. Strnadová, B. Dvořánková, J. Štork, L. Lacina, K. Smetana
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články, přehledy
NLK
Free Medical Journals
od 2006 do Před 1 rokem
ProQuest Central
od 2012-01-01
Medline Complete (EBSCOhost)
od 2014-06-01
Nursing & Allied Health Database (ProQuest)
od 2012-01-01
Health & Medicine (ProQuest)
od 2012-01-01
PubMed
32705148
DOI
10.3892/ijo.2020.5090
Knihovny.cz E-zdroje
- MeSH
- kůže cytologie patologie MeSH
- lidé MeSH
- melanocyty patologie MeSH
- melanom sekundární MeSH
- mezibuněčná komunikace * MeSH
- modely nemocí na zvířatech MeSH
- myši MeSH
- nádorové mikroprostředí * MeSH
- nádory kůže patologie MeSH
- nádory mozku sekundární MeSH
- nádory plic sekundární MeSH
- progrese nemoci MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The incidence of cutaneous malignant melanoma has been steadily increasing worldwide for several decades. This phenomenon seems to follow the trend observed in many types of malignancies caused by multiple significant factors, including ageing. Despite the progress in cutaneous malignant melanoma therapeutic options, the curability of advanced disease after metastasis represents a serious challenge for further research. In this review, we summarise data on the microenvironment of cutaneous malignant melanoma with emphasis on intercellular signalling during the disease progression. Malignant melanocytes with features of neural crest stem cells interact with non‑malignant populations within this microenvironment. We focus on representative bioactive factors regulating this intercellular crosstalk. We describe the possible key factors and signalling cascades responsible for the high complexity of the melanoma microenvironment and its premetastatic niches. Furthermore, we present the concept of melanoma early becoming a systemic disease. This systemic effect is presented as a background for the new horizons in the therapy of cutaneous melanoma.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21020189
- 003
- CZ-PrNML
- 005
- 20210830101822.0
- 007
- ta
- 008
- 210728s2020 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ijo.2020.5090 $2 doi
- 035 __
- $a (PubMed)32705148
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Kodet, Ondřej $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
- 245 10
- $a Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review) / $c O. Kodet, J. Kučera, K. Strnadová, B. Dvořánková, J. Štork, L. Lacina, K. Smetana
- 520 9_
- $a The incidence of cutaneous malignant melanoma has been steadily increasing worldwide for several decades. This phenomenon seems to follow the trend observed in many types of malignancies caused by multiple significant factors, including ageing. Despite the progress in cutaneous malignant melanoma therapeutic options, the curability of advanced disease after metastasis represents a serious challenge for further research. In this review, we summarise data on the microenvironment of cutaneous malignant melanoma with emphasis on intercellular signalling during the disease progression. Malignant melanocytes with features of neural crest stem cells interact with non‑malignant populations within this microenvironment. We focus on representative bioactive factors regulating this intercellular crosstalk. We describe the possible key factors and signalling cascades responsible for the high complexity of the melanoma microenvironment and its premetastatic niches. Furthermore, we present the concept of melanoma early becoming a systemic disease. This systemic effect is presented as a background for the new horizons in the therapy of cutaneous melanoma.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádory mozku $x sekundární $7 D001932
- 650 12
- $a mezibuněčná komunikace $7 D002450
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory plic $x sekundární $7 D008175
- 650 _2
- $a melanocyty $x patologie $7 D008544
- 650 _2
- $a melanom $x sekundární $7 D008545
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a kůže $x cytologie $x patologie $7 D012867
- 650 _2
- $a nádory kůže $x patologie $7 D012878
- 650 12
- $a nádorové mikroprostředí $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kučera, Jan $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
- 700 1_
- $a Strnadová, Karolína $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
- 700 1_
- $a Dvořánková, Barbora $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
- 700 1_
- $a Štork, Jiří $u Department of Dermatovenereology, First Faculty of Medicine, Charles University and General University Hospital, 120 00 Prague, Czech Republic
- 700 1_
- $a Lacina, Lukáš $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
- 700 1_
- $a Smetana, Karel $u Institute of Anatomy, First Faculty of Medicine, Charles University, 128 00 Prague 2, Czech Republic
- 773 0_
- $w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 57, č. 3 (2020), s. 619-630
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32705148 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101822 $b ABA008
- 999 __
- $a ok $b bmc $g 1690892 $s 1140635
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 57 $c 3 $d 619-630 $e 20200626 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350
- LZP __
- $a Pubmed-20210728